Comparison of Spinoglenoid and Suprascapular Notch Approaches and Neuromodulation of the Suprascapular Nerve Under Ultrasonography Guided in Shoulder Pain

Launched by KANUNI SULTAN SULEYMAN TRAINING AND RESEARCH HOSPITAL · Feb 27, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating two different methods for treating chronic shoulder pain by targeting a specific nerve in the shoulder area. The goal is to see which approach—either accessing the nerve through the spinoglenoid area or the suprascapular notch—is more effective when guided by ultrasound. Chronic shoulder pain can significantly impact daily life, making even simple tasks difficult, and this trial seeks to provide better treatment options for those who have not found relief from other therapies.

To participate in this study, you need to be at least 18 years old and have experienced shoulder pain for more than three months, with a pain level of 4 or higher on a scale of 0 to 10, despite trying medications and physical therapy. However, certain individuals, such as those with a history of specific medical conditions or recent surgeries, are not eligible to join. If you qualify, you can expect personalized care and close monitoring as researchers aim to find the best way to help manage your shoulder pain. Your participation could contribute to improving treatment options for many others facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over the age of 18 who have pain at or above visual analog scale (VAS) 4 despite pharmacological agents and physical therapy (passive range of motion, strengthening exercises) for more than 3 months and who meet the inclusion criteria will be included in the study.
• • Patients with complete data to be scanned in their files
• Exclusion Criteria:
• • Patients with known malignancy,
• • patients who had shoulder injections within the last 3 months,
• • patients who changed their medical analgesic treatment or underwent surgery during follow-up,
• • patients with previous shoulder surgery or deformity,
• • patients with inflammatory arthritis and fibromyalgia,
• • patients with known cervical disc herniation,
• • patients with pacemakers, pregnant women,
• • patients with chronic decompensated disease,
• • hemiplegic patients,
• • patients with major psychopathology,
• • patients allergic to medications used during the procedure,
• • patients with infection in the procedure area,
• • patients with bleeding disorders, and patients who did not agree to participate in the study were excluded from the study.